aportul videocapsulei endoscopice în stabilirea indicaţiei de tratament chirurgical în patologia...
TRANSCRIPT
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
1/21
Aportul videocapsulei endoscopice n stabilirea indicaiei
de tratament chirurgical n patologia tumoral a intestinului
subire
The Contribution of the Video Capsule Endoscopy in
Establishing the Indication of Surgical Treatment in the Tumor
Pathology of the Small Intestine
Autori: Cristin Constantin Vere1, Costin Teodor Streba1, Marius Georgescu2, Camelia
Foarf3, Alin Gabriel Ionescu1
1Clinica Medical I, Spitalul Clinic Judeean de Urgen Craiova
2Universitatea de Medicina si Farmacie Craiova
3Departamentul de Anatomie Patologic, Spitalul Clinic Judeean de Urgen Craiova
1Medical Clinic I, County Clinic Emergency Hospital of Craiova
2The University of Medicine and Pharmacy Craiova
3
The Department for Pathological Anatomy, Clinic Emergency Hospital of Craiova
1
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
2/21
REZUMAT:
Introducere Videocapsula endoscopic reprezint o metod de actualitate ce permite
explorarea sigur, neinvaziv i rapid a intestinului subire.
Material i metod Studiul a fost realizat pe 11 pacieni ce au prezentat patologie
tumoral la nivelul intestinului subire. Tumorile au fost identificate cu ajutorul capsulei
endoscopice. Diagnosticul de malignitate a fost stabilit prin examen anatomopatologic efectuat
pe piesele de rezecie chirurgical. Analiza statistic a datelor a fost fcut cu ajutorul Testului
Exact Fisher.
Rezultate Patologia tumoral a pacienilor inclui n studiu a fost reprezentat de: 3 polipi
intestinali, 2 tumori stromale benigne, 2 tumori stromale maligne, 2 adenocarcinoame, o tumor
neuroendocrin malign, un carcinom de papil duodenal. Am urmrit repartiia tumorilor maligne i
benigne n funcie de vrst. Totalitatea tumorilor maligne (n=6) au fost nregistrate la pacienii peste
60 ani, n timp ce tumorile benigne au fost observate n majoritatea cazurilor (80%, n=4) sub vrsta de
60 ani. Un singur caz cu tumor benign (polip intestinal) a avut vrsta peste 60 ani.
Discuii Dei intestinul subire reprezint cel mai lung segment al tubului digestiv,
numrul tumorilor maligne identificate la nivelul su n timpul vieii este foarte sczut. n mare
parte aceasta se datoreaz faptului c intestinul subire este greu accesibil tehnicilor de
investigaie non-invazive clasice.
Concluzii Videocapsula endoscopic reprezint un real ajutor pentru chirurg,
deocarece permite identificarea patologiei intestinului subire, furniznd informaii cu privire la
2
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
3/21
localizarea aproximativ a leziunilor, dimensiunilor i orientnd asupra etiologiei acestora.
Patologia tumoral se ntlnete predominant la persoane de vrsta a treia i se prezint sub o
multitudine de forme. Este deci necesar o metod eficient de identificare precoce a leziunilor
i un protocol care s stabileasc malignitatea.
ABSTRACT
Introduction Capsule endoscopy (CE) represents a novel method which allows safe,
non-invasive and rapid exploration of the small bowel.
Material and Method Our study was conducted on 11 patients who presented tumoral
pathology at the small bowel level. Tumors were identified by CE. Malignancy was determined
on the surgical resection piece, by histological exam. Statistic analysis of the data was
conducted using Fishers Exact Test.
Results Tumoral pathology was represented by: 3 intestinal polyps, 2 benign stromal
tumors, 2 malign stromal tumors, 2 adenocarcinoma, one neuroendocrine malign tumor, one
duodenal papilla carcinoma. We followed the presence of malign tumors in regards to age. All
malign tumors (n=6) were recorded in patients over 60 years old, while benign tumors were
recorded in most cases (80%, n=4) in people under 60 years old. One case of benign tumor
(intestinal polyp) was observed above 60 years old.
Discussion Even though the small bowel represents the longest segment of the
digestive tract, the number of malign tumors identified at its level during the patients lifetime is
very low. This is mainly due to the fact that the small bowel is virtually inaccessible to classic
non-invasive techniques.
Conclusions Capsule endoscopy represents a real help for the surgeon, as it allows
identification of small bowel pathology, giving information regarding the approximate localization
of lesions, their size and orienting on their nature. Tumoral pathology is encountered mainly
3
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
4/21
with the old age population and can be presented under a multitude of forms. It is thus
necessary an efficient method for incipient detection and a protocol to establish malignity.
KEYWORDS: Capsule endoscopy, Small Bowel, Tumor, Adenocarcinoma
REZUMAT: Dei intestinul subire reprezint cel mai lung segment al tubului digestiv,
numrul tumorilor maligne identificate la nivelul su n timpul vieii este foarte sczut. n mare
parte aceasta se datoreaz faptului c intestinul subire este greu accesibil tehnicilor de
investigaie non-invazive clasice. Videocapsula endoscopic reprezint o metod de actualitate
ce permite explorarea sigur, neinvaziv i rapid a acestui segment. Ea reprezint un real ajutor
pentru chirurg, deocarece permite identificarea patologiei intestinului subire, furniznd informaii cu
privire la localizarea aproximativ a leziunilor, dimensiunilor i orientnd asupra etiologiei acestora.
Este eficient n screening, iar combinat cu tehnicile intervenionale clasice, urmate de analizarea
histopatologic i imunohistochimic a pieselor de biopsie, stabilete cu mare precizie diagnosticul de
malignitate al leziunilor.
ABSTRACT: Even though the small bowel represents the longest segment of the
digestive tract, the number of malign tumors identified at its level during the patients lifetime is
very low. This is mainly due to the fact that the small bowel is virtually inaccessible to classic
non-invasive techniques. Capsule endoscopy represents a novel method which allows safe,
non-invasive and rapid exploration of this segment. It represents a real help for the surgeon, as
it allows identification of small bowel pathology, giving information regarding the approximate
localization of lesions, their size and orienting on their nature. It is an efficient screening
method, and combined with classic interventional methods and followed by histological and
4
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
5/21
immunohistochemical analysis of the biopsy pieces, determines the precise malignity diagnosis
for lesions.
Introducere
Progresul tehnologic actual a facut posibil introcerea de noi tehnici de explorare non-
invazive a tractului digestiv.
Videocapsula endoscopic (VCE) permite evaluarea non-invaziv a oricrui segment al
tractului digestiv, de la esofag la colon, n prezent fiind folosit n principal pentru explorarea
intestinului subire, unde poate identifica leziuni care nu pot fi detectate prin metode convenionale. (1)
Numrul de aplicaii ale acestei metode este n continu cretere. VCE poate fi folosit cu
succes n diagnosticarea sngerrilor obscure gastrointestinale, (2-5) bolii Crohn, (6, 7) bolii celiace i
complicaiilor ei, (8, 9) leziunilor vasculare intestinale (10) sau patologiei tumorale. (11, 12)
Introducerea explorrii intestinului subire cu ajutorul VCE reprezint un real ajutor pentru
chirurg, deocarece permite identificarea patologiei intestinului subire, furniznd informaii cu privire la
localizarea aproximativ a leziunilor, dimensiunilor i orientnd asupra etiologiei acestora.
Introduction
The present technological progress has made possible the introduction of new tehniques of
non-invasive exploration of the digestive tract.
5
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
6/21
The video capsule endoscopy (VCE) allows the non-invasive evaluation of each segment of
the digestive tract, from the esophagus to the colon, presently being used mainly for the exploration of
the small intestine, where it can identify lesions that cant be detected by conventional means. (1)
The number of applications for this method is steadily rising. VCE can be succesfully used in
diagnosticating obscure gastrointestinal bleeding (2-5), Crohn disease (6, 7) celiac disease and its
complications (8, 9) intestinal vascular lesions (10) or tumor pathology (11, 12)
The introduction of the exploration of the small intestine by means of VCE represents a real
help for the surgeon, because it allows the identification of the pathology affecting the small intestine
and supplying information regarding the approximative location of lesions, their dimensions and an
orientation on their etiology.
Material i metod
Din totalul de pacieni investigai cu ajutorul VCE n perioada iunie 2008 martie 2009 n
cadrul Clinicii 1 de Medicin Intern i Gastroenterologie a Spitalului Clinic Judeean de Urgen
Craiova, 11 pacieni au prezentat patologie tumoral a intestinului subire, stabilindu-se indicaia de
tratament chirurgical.
Criteriul de includere n studiu a fost reprezentat de suspiciunea prezenei de tumori ale
intestinului subire, dup excluderea localizrii la nivelul altor segmente ale tractului digestiv prin
endoscopie digestiv superioar sau colonoscopie total.
Lotul a fost compus din 6 brbai (54,54%) i 5 femei (45,45%), cu vrste cuprinse ntre 54 i 79 ani,
media fiind de 63,72 ani; deviaia standard 7,11, interval de ncredere (CI) 95% 4,77.
Material and Method
From the total number of patients investigated by VCE in the June 2008 - March 2009 period
within Internal Medicine and Gastroenterology Clinic 1 of the County Clinic Emergency Hospital of
Craiova, 11 patients presented tumor pathology of the small intestine, establishing the
indication of surgical treatment.
6
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
7/21
The study inclusion criterion was represented by the suspicion of presence of tumors of
the small intestine , after excluding their localisation at the level of other segments of the
digestive tract by upper digestive endoscopy or total colonoscopy.
The study group was made up of 6 men (54.54%) and 5 women (45.45%), aged between
54 and 79 years of age, the average being 63.72 years; standard deviation 7.11, confidence
interval (CI) 95% 4.77.
Fiecrui pacient i s-a administrat videocapsula dup o pregtire prealabil. Pregtirea
standard a constat n restricie alimentar 12-16 ore nainte de nceperea explorrii, asociat cu lavajul
intestinal cu soluie de polietilenglicol (PEG) (2 l) administrat n preziua explorrii cu 12-16 ore nainte
de nceperea nregistrrii. Nu am folosit n mod obinuit pregtirea intestinului subire cu prokinetice,
deoarece informaii recente au artat c astfel de tehnici nu sunt ntotdeauna necesare (13). Pacienii
au putut consuma lichide limpezi la 2 ore dup ingestia capsulei i un prnz lejer la 4 ore dup
ingestia videocapsulei (13, 14). Pacienii au fost monitorizai timp de 8 ore.
Videocapsula endoscopic (VCE) este un dispozitiv de 11/26 mm, cntrind 3.7 g. Este
capabil s trimit dou imagini pe secund, n sistem radio (o nregistrare obinuit de 8 ore
cuprinznd peste 50.000 de imagini), cmpul de vizibilitate fiind de 140 grade, cu o rat de mrire de
1:8 i un cmp de profunzime de la 1 la 30 mm. Permite vizualizarea leziunilor cu dimensiuni de
minim 0.1 mm. Principalele sale componente sunt un dom optic i un sistem de lentile, ase LED-uri
(light emitting diodes) pentru iluminare, modulul de camera CMOS (complementary metal oxide
silicone), un circuit special ASIC (application specific integrated circuit) i o anten care ajut la
transmiterea imaginilor ctre electrozii ataai de corp, n timp ce permite totodat nregistrarea datelor
pe un mic dispozitiv portabil de stocare. (15)
Each patient was administered the video capsule after a preliminary preparation. Standard
preparation consisted of alimentary restrictions for 12-16 hours before the exploration, associated with
intestinal lavage with a solution of polietylenglycol (PEG) (2 l) administered the day before exploration
12-16 hours before starting the recording. We did not usually use the preparation of the small intestine
7
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
8/21
with prokinetics because recent information has shown that such techniques are not always necessary
(13). Patients were able to consume clear liquids 2 hours after ingesting the capsule and a light lunch
4 hours after ingesting the capsule (13, 14) Patients were monitored for 8 hours.
The video capsule endoscopy (VCE) is a 11/26 mm device that weighs 3.7 grams. It is
capable of sending 2 images per second on a radio system (an average 8 hour recording containing
over 50 000 images), the visibility field being of 140 degrees, with a zoom rate of 1:8 and depth of field
of 1 to 30 mm. It allows the visualisation of lesions with dimensions of a minimum of 0.1 mm. Its main
components are an optic dome and a lens system, 6 LEDs (light emitting diodes) for illumination, the
CMOS camera module (complementary metal oxide silicone), a special ASIC circuit (application
specified integrated circuit) and an antenna that helps transmitting images to the electrodes attached
to the body, while also permitting the recording of data on a small portable storage device. (15)
n fiecare caz s-a intervenit chirurgical, practicndu-se enterectomie segmentar n 10 cazuri
(91%) i duodenopancreatectomie cefalic ntr-un caz. Piesele operatorii au fost trimise ctre
Departamentul de Patologie al Spitalului Clinic de Urgen Craiova, unde au fost pregtite i
prelucrate histopatologic.
Diagnosticul de malignitate a fost dat de examenul histopatologic. Orientarea probelor a
reprezentat cel mai important pas, implicnd evaluarea rapid a vilozitilor intestinale imediat dup
recoltarea probelor. Fixarea s-a fcut cu formol 10%. Deshidratarea i includerea n blocuri de
parafin a fcut posibil conservarea pieselor importante. Colorarea final a fost fcut cu colorani
obinuii Hematoxilin-Eozin, Van Gieson, acid periodic Schiff, Gmri (folosit n special pentru
fibrele de reticulin).
Prelucrarea statistic a rezultatelor i descrierea loturilor au fost efectuate folosindu-se
metode de statistic descriptiv i Testul Exact al lui Fisher (test pentru verificarea semnificaiei
statistice folosit pe eantioane de mici dimensiuni). (16)
Surgical intervention was made in each case, practicising a segmentary enterectomy in 10
cases (91%) and cephalic duodeno-pancreatomy in one case. The surgically prelevated samples were
8
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
9/21
sent to the Pathology Department of the Clinic Emergency Hospital of Craiova, where they were
histopathologically prepared and processed.
The malignancy diagnosis was given by the histopathological exam. The orientation of
samples represented the most important step, implicating a rapid evaluation of the intestinal vilosities
immediately after prelevating samples. 10 % formol was used to FIX SAMPLES. Dehydration and
inclusion in paraffin blocks made the conservation of important samples possible. Final coloration was
made with standard colorants Hematoxylin-Eosin, Van Gieson, Periodic Acide Schiff, G mri (used
especially for reticulin fibers).
Statistical processing of results and description of groups were made using the methods of
descriptive statistics and the Fishers Exact Test (test for verifying the statistical significance which is
used on small size groups)
Rezultate
Lotul a cuprins 11 pacieni ce au prezentat patologie tumoral, investigai cu ajutorul VCE i
supui interveniei chirurgicale. Lotul a fost structurat astfel: 54,54% brbai (n=6) i 45,45% femei
(n=5), cu vrste cuprinse ntre 54 i 79 ani, media fiind de 63,72 ani; deviaia standard 7,11, interval
de ncredere (CI) 95% 4,77. Pentru efectuarea testelor statistice lotul a fost mprit n funcie de sex,
vrst i patologie.
Patologia tumoral a pacienilor inclui n studiu a fost reprezentat de: 3 polipi intestinali, 2
tumori stromale benigne, 2 tumori stromale maligne, 2 adenocarcinoame, o tumor neuroendocrin
malign, un carcinom de papil duodenal. (vezi tabel 1)
Results
The group was made up of 11 patients suffering from tumor pathology, investigated by VCE
and surgically intervened on. The structure of the group was: 54.54% men (n=6_ and 45.45% women
(n=5), ages between 54 and 79 years of age, average being 63.72 years; standard deviation 7.11,
9
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
10/21
confidence interval (CI) 95% 4.77. The group was divided according to sex, age and pathology for
statistical testing.
Tumor pathology of patients included in the study was made up of: 3 intestinal polyps, 3
benigne stromal tumors, 2 maligne stromal tumors, 2 adenocarcinoma, 1 neuroendocrine maligne
tumor, 1 duodenal papilla carcinoma. (see table 1)
Men WomenPolyps 2 1Benigne Stromal Tumor 0 1Maligne Stromal Tumor 3 0Neuro-endocrine Tumor 0 1Adenocarcinoma 1 1Duodenal Papilla Carcinoma 0 1Total 6 5
Table 1. Repartition by Sex of Tumor Pathology
Tumorile benigne au reprezentat 45,45% din total (polipi 27,27%; tumori stromale benigne
18,18%), patologia tumoral malign fiind repartizat astfel: 18,18% tumori stromale maligne, 18,18%
adenocarcinoame, 9,09% tumori neuroendocrine, 9,09% carcinoame de papil duodenal.
Dintre cei ase brbai inclui n lot, 33,3% (n=2) au prezentat tumori benigne (polipi intestinali), restul
fiind diagnosticai cu tumori maligne (trei tumori stromale maligne i un caz cu adenocarcinom).
Dintre cele cinci femei incluse n studiu, 40% (n=2) au prezentat tumori benigne (un polip
intestinal i o tumor stromal benign), restul fiind diagnosticate cu tumori maligne (o tumor
neuroendocrin, un adenocarcinom i un carcinom de papil duodenal).
Benigne tumors represented 45.45% of the total (polyps 27.27%; benigne stromal tumors
18.18%), while maligne tumor pathology was represented thus: 18.18% maligne stromal tumors,
18.18% adenocarcinoma, 9.09% neuroendocrine tumors, 9.09% duodenal papilla carcinoma. Of the
six men included, 33.3 % (n=2) presented benigne tumors (intestinal polyps), the others being
diagnosed with maligne tumors (3 stromal maligne tumors and 1 case of adenocarcinoma).
Of the five women included, 40 % (n=2) presented benigne tumors (one intestinal polyps, one
benigne stromal tumor), the others being diagnosed with maligne tumors (one neuro-endocrine tumor,
one adenocarcinoma and one duodenal papilla carcinoma).
10
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
11/21
Am urmrit repartiia tumorilor maligne i benigne n funcie de vrst, pornind de la ipoteza c
patologia malign se ntlnete predominant peste 60 de ani, n timp ce tumorile benigne sunt
predominant ntlnite sub aceast vrst. Vrsta de 60 ani a fost luat ca punct de referin n
divizarea lotului, fiind apropiat de vrsta medie a acestuia. Pentru aplicarea Testului Exact al lui
Fisher, lotul a fost submprit n dou subloturi, sub i peste 60 de ani. Totalitatea tumorilor maligne
(n=6) au fost nregistrate la pacienii peste 60 ani, n timp ce tumorile benigne au fost observate n
majoritatea cazurilor (80%, n=4) sub vrsta de 60 ani. (vezi tabel 2 i 3) Un singur caz cu tumor
benign (polip intestinal) a avut vrsta peste 60 ani. Aplicnd testul Fisher s-a obinut o valoare
p=0,01515 2-Tail (CI 95% valoare prag 0,05), rezultat semnificativ statistic ce verific ipoteza iniial.
We tracked the repartition of maligne and benigne tumors by age, starting from the hypothesis that
maligne pathology appears predominantly over 60 years of age, while benigne tumors appear
predominantly before this age. The age of 60 years was taken as a referrence point in dividing the
group, since it is close to the average age of the group. For the application of Fishers Exact Test, the
group was subdivided in two subgroups, over and under 60 years. All the maligne tumors (n=6) were
observed on patients over 60 years, while the majority of benigne tumors (80%, n=4) were observed
under 60 years. By applying Fishers Exact Test a p value of 0.01515 2-Tail (CI 95% threshold value
0.05) was obtained, a statistically significant result which verifies the initial hypothesis.
60 years TotalMaligne Tumors 0 6 (54,54%) 6 (54,54%)Benigne Tumors 4 (27,27%) 1 (11,11%) 5 (45,45%)
Total 4 (27,27%) 7 (72,72%) 11 (100%)Table 2. Tumor Pathology of the Small Intestine Table of Incidence
Benigne Tumors (45,45%) Maligne Tumors (54,54%) Total
PolypsStromalTumors
NeuroendocrineTumors
Adenocarcinoma
StromalTumors
Duodenalpapilla
carcinoma
60years
1 (9,09%) 0 1(9,09%)
2 (18,18%) 2 (18,18%) 1(9,09%)
8 (72,72%)
11
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
12/21
Total 3 (27,27%) 2 (18,18%) 1(9,09%)
2 (18,18%) 2 (18,18%) 1(9,09%)
11 (100%)
Table 3. Tumor Pathology Repartition by Etiology and Age Groups
Discuii
Dei intestinul subire reprezint 75% din lungimea i 90% din suprafaa de absorbie a
tractului intestinal, tumorile maligne prezente la nivelul su reprezint mai puin de 5% din totalul
cancerelor gastrointestinale. (17, 18) Ele reprezint de asemenea mai puin de 0,3% din totalul
neoplasmelor i sunt deseori prost diagnosticate sau descoperite n stadii foarte trzii (18,19) Studii
recente au artat o cretere a incidenei tumorilor intestinului subire pe tot cuprinsul globului. (18, 20-
24) Hurst RD aproximeaz c anual n Statele Unite se diagnosticheaz aproximativ 140.000 de
cazuri de cancer colorectal, 22.000 de cazuri noi de cancere gastrice, comparativ cu doar 4.500-5.000
de cazuri de cancer ale intestinului subire (25).
Discussions
Although the small intestine represents 75 % of the length and 90 % of the absorbtion surface
of the intestinal tract, maligne tumors present at its level represent less than 5 % of the total of
gastrointestinal cancers. (17, 18) They also represent less than 0.3 % of the total of neoplasms and
are often poorly diagnosed or discovered in very late stages (18, 19) Recent studies have shown an
increase in incidence of small intestine tumors all over the globe. (18, 20-24) Hurst RDs
approximations of annual diagnostics in the United States, are of approximatively 140 000 cases of
colorectal cancer, 22 000 new cases of gastric cancers, compared to only 4.500 5000 cases of small
intestine cancer (25).
ntr-un studiu retrospectiv recent, Karl Y. Bilimoria i colab. (26) au descris caracteristicile unui lot de
65.843 de pacieni inclui in perioada 1985-2005 n National Cancer Data Base (NCDB) i in
programul Epidemiology and End Results (SEER, 19732004). Dintre acetia, 25.339 (37.4%) au
fost diagnosticai cu tumori carcinoide, 25.053 (36,9%) cu adenocarcinoame, 11.711 (17,3%) limfoame
i 5.740 (8,4%) adenocarcinoame. Repartiia pe sexe a relevat o uoar predominan a brbailor
(54% vs 46%), n timp ce vrsta medie a fost 67 ani (cu vrste cuprinse ntre 56 i 76 ani). S-a
12
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
13/21
observat o cretere a incidenei de la 11,8 cazuri la milion n 1973, la 22,7 cazuri n 2004. De remarcat
c studiul nu a inclus cazurile diagnosticate la autopsie.
Incidena total n anul 2005 a fost de 8,4/100.000 locuitori, dintre care 85-90% au fost descoperite
ntmpltor la autopsie. (27)
In a recent retrospective study, Karl Y. Bilimoria and collaborators (26) described the characteristics of
a group of 65.843 patients included in the 1985-2005 period in the National Cancer Data Base
(NCDB) and in the Epidemiology and End Results program (SEER, 1973-2004). Of these, 25.339
(37.4%) were diagnosed with carcinoid tumors, 25.053 (36.9%) with adenocarcinoma, 11.711 (17.3%)
with lymphoma and 5.740 (8.4%) with adenocarcinoma. Repartition by sex showed a slight
predominance of men (54% vs 46%), while the average age was 67 years (ages between 56 and 76
years). An increase in incidence from 11.8 cases per million in 1973 to 22.7 cases per million in 2004
was noticed. It is worthy of note that the study did not include cases diagnosed by autopsy.
Total incidence in 2005 was of 8.4/100 000 people, of which 85%-90% were discovered by chance
when autopsied. (27)
Datorit numrului mare de cazuri nregistrate post-mortem, este suficient de clar c o metod
eficient de descoperire incipient a acestei patologii tumorale este necesar. Modalitile clasice de
diagnostic pentru tumori ale intestinului subire cuprind endoscopia digestiv superioar (pentru leziuni
ale dudenului i jejunului proximal), metode radiografice (tomografie computerizat sau seriografii).
Leziunile localizate dincolo de ligamentul Treitz pun probleme majore datorit lungimii intestinului
subire. (28)
Astfel s-a impus gsirea unor modaliti diagnostice noi, sigure i eficace, cu tolerabilitate bun.
Videocapsula endoscopic ntrunete condiiile necesare pentru a fi o astfel de investigaie, uurina
folosirii, combinat cu tolerabilitatea bun, numrul minim de efecte secundare i rata diagnostic
ridicat recomandnd-o ca metod diagnostic de mare valoare n identificarea precoce a patologiei
intestinului subire. (29,30)
Due to the large number of cases recorded post-mortem, it is sufficiently clear that an efficient method
of early discovery of this tumor pathology is necessary. Classic diagnosis methods for tumors of the
13
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
14/21
small intestine include upper digestive endoscopy (for lesions of the duoden and proximal jejunum),
radiographic methods (computerized tomography or seriography). Lesions located beyond the
ligament of Treitz are very difficult to diagnose because of the length of the small intestine. (28)
Thus, it becomes a necessity to find new means of diagnostic that are effective, well tolerated, and
sure. The video capsule endoscopy fulfills all the necessary for such an investigation, ease of use,
combined with good tolerability, a minimum number of side effects and a high diagnosis rate all
recommending it as a high value diagnostic method for early identification of small intestine pathology.
(29, 30)
Unul din posibilele neajunsuri ale tehnologiei VCE este reprezentat de contraindicaia
absolut n cazul obstruciei. Exist pericolul reteniei capsulei la nivelul stricturii, cu rezultate
catastrofale pentru pacient. Astfel, a fost introdus o metod de control, o capsul ce verific
continuitatea tractului intestinal, numit patency capsule. (31) Capsula se resoarbe dup o anumit
perioad, impactarea sa la nivelul unei posibile stenoze nereprezentnd un pericol. Conine un
emitor RFID (radio frequency identificator=identificator n spectru radio), care face posibil
detectarea locaiei exacte unde capsula se oprete. Aceast nou modalitate de control sporete
eficacitatea sistemului VCE, suplimentnd n acelai timp capacitile sale diagnostice. (31,32)
One of the possible shortcomings of the VCE technology is represented by the absolute
contra-indication in the case of obstruction. This holds the danger of capsule retention at the stricture
level, with catastrophic results for the patient. Thus, a new control method was introduced, a capsule
which verifies the continuity of the intestinal tract, called patency capsule. (31) This capsule is
absorbed after a certain period, its impact on the level of a possible stenosis being of no concern. It
contains a RFID emitter (radio frequency identificator), which makes possible to detect the exact
location where the capsule stops. This new method of control increases the efficiency of the VCE
system, while simultaneously supplementing its diagnosis capabilities. (31, 32)
A fost pus la punct un sistem endoscopic de vizualizare a intestinului subire: enteroscopia cu
un singur balon (SBE), cunoscut drept enteroscopia mpinge-i-trage . A fost proiectat n 1997
(33). n 2001, cercetrorii japonezi au dezvoltat primul sistem endoscopic specializat. Aceasta tehnic
14
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
15/21
permite examinarea direct a intestinului subire. Poate fi folosit pentru prelevarea de biopsii, sau
pentru aplicarea tratamentului hemostatic, acolo unde este cazul. Poate fi executat de un singur
enteroscopist, spre deosebire de enteroscopia cu dublu balon, care necesit minim doi operatori.
Anestezia standard poate fi utilizat. Enteroscopia poate fi realizat fie pe cale oral sau pe cale
anal, n funcie de localizarea leziunilor, care au fost descoperite prin alte tehnici non-invazive, cum
este VCE. (34,35)
An endoscopic system of visualizing the small intestine was implemented: single-balloon
enteroscopy (SBE), known as push-and-pull enteroscopy It was designed in 1997 (33). In 2001,
Japanese researchers implemented the first specialized endoscopic system. This technique allows
direct examination of the small intestine. It can be used to prelevate biopsies or to apply hemostatic
treatment where needed. It can be executed by a single enteroscopist, unlike double-ballon
enteroscopy, which requires a minimum of 2 operators. Standard anesthesis can be used. The
enteroscopic approach can be oral or anal, depending on the localization of lesions, which were
discovered by other non-invasive techniques such as VCE. (34,35)
Pregtirea histologic a probelor de biopsie a fost cea care a furnizat diagnosticul de
certitudine. Orientarea a fost cel mai important pas, uurnd mult diagnosticarea. Prelevarea corect a
probelor de biopsie este obligatorie pentru un diagnostic de acuratee, mai ales cnd implic
evaluarea vilozitilor intestinului subire sau atunci cnd privete leziunile neoplazice sau displazice.
Este de preferat s se treac la fixare imediat dup intervenia chirurgical. Prelevarea pieselor
biopsice poate fi fcut uor dac este folosit o lup. Trebuie efectuat rapid i cu mult grij, pentru
a nu afecta mucoasa intestinal. Protocoalele utilizate au evideniat caracteristici histologice specifice
tipurilor tumorale benigne sau maligne, furniznd suficiente informaii pentru stabilirea unui diagnostic
de precizie n ceea ce privete malignitatea.
Histologic preparation of biopsy samples was what gave the diagnostic certainty. Orientation
was the most important step, simplifying diagnosis by a great deal. Correct prelevation of biopsy
samples is mandatory for an accurate diagnosis, especially when it involves the evaluation of small
intestine vilosities or when it regards neoplasic or displasic lesions. It is prefferable to FIX immediately
15
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
16/21
after surgical intervention. Prelevating biopsy samples can be made easier if a magnifying glass is
used. It must be made quickly and with great care, so as not to affect the intestinal mucosa. The
protocols used have shown histologic characteristics specific to the types of benigne or maligne
tumors, supplying sufficient information to establish a precision diagnosis regarding malignity.
Imunohistochimia reprezint o metod relativ nou, ce permite localizarea proteinelor
specifice, utiliznd reacia anticorp-antigen. (36) Este folosit cu success n diagnosticarea cu
acuratee a leziunilor maligne, identificnd markeri tumorali specifici fiecrui tip de neoplasm malign.
Toate aceste tehnici vin n sprijinul chirurgului, direcionnd intervenia chirurgical i
tratamentul oncologic.
Immunohistochemistry is a relatively new method, which allows the localization of specific
proteins by utilizing the antigen-antibody reaction. (36) It is successfully used in accurate diagnosis of
malignant lesions, by identifying tumor markers that are specific to each type of malignant neoplasm.
All these techniques come to the support of the surgeon, by direction the surgical intervention
and the oncologic treatment.
Concluzii
Patologia tumoral a intestinului subire este subevaluat n raport cu cea a celorlalte
segmente ale tubului digestiv, rata de detecie n timpul vieii fiind mult mai sczut dect n alte
cazuri. Se ntlnete predominant la persoane de vrsta a treia i se prezint sub o multitudine de
forme. Este deci necesar o metod eficient de identificare precoce a leziunilor i un protocol care s
stabileasc malignitatea.
Conclusions
Tumor pathology of the small intestine is under-evaluated by comparison with the other
segments of the digestive tract, detection rate during life being much lower than other cases. It is
predominantly occuring in third age persons and it presents under a multitude of forms. It is therefore
necessary to find an efficient method of early identification of lesions and a protocol which would
establish malignancy.
16
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
17/21
Videocapsula endoscopic reprezint fr ndoial o metod modern, eficient, de
identificare a leziunilor tumorale. Ea se poate dovedi un ajutor preios pentru chirurg n toate etapele
de diagnostic. Fiind o metod neinvaziv i avnd un grad de acceptabilitate mare din partea
pacienilor, poate fi folosit cu succes n screening-ul multiplelor afeciuni ntlnite la nivelul tubului
digestiv subire. Combinat cu capsula patency i cu metodele enteroscopice moderne (SBE), i
lrgete acurateea diagnostic i uureaz munca chirurgului, ajutnd n acelai timp pacientul prin
reducerea amplorii interveniei chirurgicale.
Folosirea tehnicilor de histologie i imunohistochimie duce la un diagnostic precis de
malignitate pentru toate tumorile intestinului subire, direcionnd efortul terapeutic i evalund corect
patologia.
The video capsule endoscopy is, without doubt, a modern effective means of identifying tumor
lesions. It can prove to be of precious help to the surgeon in all steps of the diagnosis. Being a non-
invasive technique and having a high degree of acceptability from patients, it can be successfully used
in screening the multiple pathologies of the small intestine. When combined with the patency capsule
and modern enteroscopic methods (SBE), it widens its diagnosis accuracy and eases the work of the
surgeon, simultaneously helping the patient by reducing the extent of the surgical intervention.
By using histology and immunohistochemistry techniques it leads to a precise malignancy
diagnosis for all tumors of the small intestine, directing therapeutic efforts and correctly evaluating the
pathology.
Bibliography:
1. Fritscher-Ravens A, Swain CP. The wireless capsule: new light in the darkness. Dig Dis
2002;20(2):127-33.
17
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
18/21
2. Bresci G, Parisi G, Bertoni M, Tumino E, Capria A. The role of video capsule endoscopy for
evaluating obscure gastrointestinal bleeding: usefulness of early use. J Gastroenterol 2005;
40: 256-259.
3. Pennazio M, Santucci R, Rondonotti E, Abbiati C, Beccari G, Rossini FP, De Franchis R.
Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: report of
100 consecutive cases. Gastroenterology 2004; 126: 643-653.
4. Triester SL, Leighton JA, Leontiadis GI, et al. A meta-analysis of the yield of capsule
endoscopy compared to other diagnostic modalities in patients with obscure gastrointestinal
bleeding. Am J Gastroenterol 2005;100:240718.
5. Van Gossum A. Prospective comparative study between push-enteroscopy and wireless video
capsule in patients with obscure digestive bleeding. Gastroenterology 2002; 122:A-683
Abstract.
6. Eliakim R, Fischer D, Suissa A, Yassin K, Katz D, Guttman N, et al. Wireless capsule video
endoscopy is a superior diagnostic tool in comparison to barium follow-through and
computerized tomography in patients with suspected Crohns disease. Eur J Gastroenterol
Hepatol 2003;15(4):363-7.
7. Ge ZZ, Hu YB, Xiao SD. Capsule endoscopy in diagnosis of small bowel Crohns disease.
World J Gastroenterol 2004;10:134952
8. Daum S, Wahnschaffe U, Glasenapp R, Borchert M, Ullrich R, Zeitz M, Faiss S. Capsule
endoscopy in refractary celiac disease. Endoscopy. 2007 May;39(5):455-8.
9. Rima Petroniene, Elena Dubcenco, Jeffrey P. Baker, Clifford A. Ottaway, Shou-Jiang Tang,
Simon A. Zanati, Cathy J. Streutker, Geoffrey W. Gardiner, Ralph E. Warren, Khursheed N.
Jeejeebhoy. Capsule Endoscopy in Celiac Disease: Evaluation of Diagnostic Accuracy and
Interobserver Agreement. The American Journal of Gastroenterology; 2005 100, (3):
685 694.
10. Bhinder F, Schneider DR, Farris K,Wolff R, Mitty R, Lopez M, et al. NSAID associated small
intestinal ulcers and strictures: diagnosis by video capsule endoscopy (abstract).Gastroenterology 2002;122:A345.
11. E. Estvez, B. Gonzlez-Conde, J. L. Vzquez-Iglesias, P. A. Alonso, M. de los Angeles
Vzquez-Milln, R. Pardeiro. Incidence of tumoral pathology according to study using capsule
18
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
19/21
endoscopy for patients with obscure gastrointestinal bleeding. Surgical Endoscopy. 2007;
volume 21 (10)
12. Marco Pennazio, Emanuele Rondonotti, Roberto de Franchis. Capsule endoscopy in
neoplastic diseases. World J Gastroenterol 2008; 14(34): 5245-5253
13. Mergener K, Ponchon T, Gralnek I, Pennazio M, Gay G, Selby W, Seidman EG, Cellier C,
Murray J, de Franchis R, Rosch T, Lewis BS. Literature review and recommendations for
clinical application of small-bowel capsule endoscopy, based on a panel discussion by
international experts. Consensus statements for small-bowel capsule endoscopy, 2006/2007.
Endoscopy 2007; 39: 895-909.
14. C. Gheorghe, R. Iacob. Explorarea endoscopica cu videocapsula. Viata Medicala 2006; no.
43/27 octombrie 2006: pag. 7
15. Sachdev MS, Ismail MK. Capsule endoscopy: a review. South Med J 2008; 101: 407-414
16. Mehta, Cyrus R; Patel, Nitin R; Tsiatis, Anastasios A. Exact significance testing to establish
treatment equivalence with ordered categorical data. Biometrics 1984; 40: 819825
17. Greenfield LJ, Mulholland MW, Oldham KT, et al. Greenfields Surgery: Scientific Principles
and Practice. 4th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006.
18. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:7196
19. DiSario JA, Burt RW, Vargas H, McWhorter WP. Small bowel cancer: epidemiological andclinical characteristics from a population-based registry. Am J Gastroenterol. 1994;89:699-701
20. Chow JS, Chen CC, Ahsan H, et al. A population-based study of the incidence of malignant
small bowel tumours: SEER, 19731990. Int J Epidemiol. 1996;25:7224.
21. Hatzaras I, Palesty JA, Abir F, et al. Small-bowel tumors: epidemiologic and clinical
characteristics of 1260 cases from the connecticut tumor registry. Arch Surg. 2007;142:229
235.
22. Neugut AI, Jacobson JS, Suh S, et al. The epidemiology of cancer of the small bowel. CancerEpidemiol Biomarkers Prev. 1998;7:243251.
23. Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United
States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control.
2005;16:781787.
19
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
20/21
24. Severson RK, Schenk M, Gurney JG, et al. Increasing incidence of adenocarcinomas and
carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev.
1996;5:81 84.
25. HURST RD. Epidemiology of Small-Bowel Tumors. In Epidemiology of Small-Bowel Tumors,
PMPH-USA, 2002
26. Bilimoria KY, Bentrem JD, Clifford Y. Charles L. Bennett LC, Talamonti, MS. Small Bowel
Cancer in the United States: Changes in Epidemiology, Treatment, and Survival Over the Last
20 Years. Annals of Surgery, 2009; Volume 249, Number 1, January
27. De Herder WW. Tumours of the midgut (jejunum, ileum and ascending colon, including
carcinoid syndrome). Best Pract Res Clin Endocrinol Metab 2005; 19:705-715
28. Hatzaras I, Palesty JA, Abir F, Sullivan P, Kozol RA, Dudrick JS, Longo WE. Small-Bowel
Tumors: Epidemiologic and Clinical Characteristics of 1260 Cases From the ConnecticutTumor Registry. ARCH SURG, 2007; VOL 142, MAR: 229-235.
29. Napierkowski JJ, Maydonovitch CL, Belle LS, Brand WT Jr, Holtzmuller KC. Wireless capsule
endoscopy in a community gastroenterology practice. J Clin Gastroenterol. 2005;39:36-41.
30. Appleyard M, Fireman Z, Glukhovsky A, et al. A randomized trial comparing wireless capsule
endoscopy with push enteroscopy for the detection of small-bowel lesions. Gastroenterology.
2000;119:1431-1438.
31. Delvaux M, Ben Soussan E, Laurent V, et al. Clinical evaluation of the use of the M2A patencycapsule system before a capsule endoscopy procedure, in patients with known or suspected
intestinal stenosis. Endoscopy 2005;37:8017.
32. Signorelli C, Rondonotti E, Villa F, et al. Use of the Given patency system for the screening of
patients at high risk for capsule retention. Dig Liver Dis 2006;38:32630
33. Yamamoto H, Sekine Y, Sato Y, Higashizawa T, Miyata T, Iino S, et al. Total enteroscopy with
a nonsurgical steerable double balloon method. Gastrointest Endosc 2001;53:216-20
34. Tomoyuki T, Yoshhihide F, Yasuharu S. Insertion Technique of the New Single Balloon
Enteroscope and Its Practical Usage. Published in collaboration with Olympus Medical
Systems Corp.
35. Kazuo O, Shin-ei. Practical Usage of the Single Balloon Enteroscope. Published in
collaboration with Olympus Medical Systems Corp.
20
-
7/28/2019 Aportul videocapsulei endoscopice n stabilirea indicaiei de tratament chirurgical n patologia tumoral a
21/21
36. Ramos-Vara, JA. Technical Aspects of Immunohistochemistry. Vet Pathol, 2005: 42: 405426.
doi:10.1354/vp.42-4-405
21